We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+6.72%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$34B
AUM Growth
+$4.4B
(+15%)
Cap. Flow
+$3.11B
Cap. Flow
% of AUM
9.14%
Top 10 Holdings %
Top 10 Hldgs %
11.75%
Holding
2,403
New
160
Increased
1,020
Reduced
1,025
Closed
188
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$308M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$249M |
| 3 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$221M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$217M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$96.7M |
| 2 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
+$85M |
| 3 |
AGN
Allergan Inc
AGN
|
+$64.4M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$58.1M |
| 5 |
PepsiCo
PEP
|
+$54.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Technology | 10.33% |
| 4 | Consumer Staples | 8.3% |
| 5 | Industrials | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Illumina
ILMN
$29.6B
| $149M | 0.44% |
827,382
+198,014
| +31% | +$37.3M |
|
27
Kroger
KR
$34.3B
| $148M | 0.44% |
3,868,584
+149,166
| +4% | +$5.32M |
|
28
AT&T
T
$161B
| $148M | 0.43% |
6,000,246
-1,076,183
| -15% | -$27.4M |
|
29
Gilead Sciences
GILD
$162B
| $146M | 0.43% |
1,491,841
+85,660
| +6% | +$8.7M |
|
30
Pfizer
PFE
$140B
| $144M | 0.42% |
4,374,226
+301,416
| +7% | +$9.58M |
|
31
Biogen
BIIB
$29.7B
| $144M | 0.42% |
341,875
-41,881
| -11% | -$16.5M |
|
32
Salesforce
CRM
$133B
| $142M | 0.42% |
2,128,658
+264,108
| +14% | +$16.4M |
|
33
Intel
INTC
$493B
| $141M | 0.42% |
4,522,577
-248,981
| -5% | -$8.4M |
|
34
Constellation Brands
STZ
$22.2B
| $141M | 0.42% |
1,215,678
+77,469
| +7% | +$8.72M |
|
35
CVS Health
CVS
$137B
| $141M | 0.41% |
1,367,639
+253,273
| +23% | +$25.6M |
|
36
Celldex Therapeutics
CLDX
$2.78B
| $132M | 0.39% |
+315,796
| New | +$113M |
|
37
Alnylam Pharmaceuticals
ALNY
$35.7B
| $131M | 0.38% |
1,254,525
+396,842
| +46% | +$40.2M |
|
|
WBA
38
DELISTED
Walgreens Boots Alliance
WBA
| $131M | 0.38% |
1,546,783
+608,528
| +65% | +$48.5M |
|
39
Alkermes
ALKS
$8.88B
| $129M | 0.38% |
2,119,760
+677,025
| +47% | +$46.3M |
|
40
Hain Celestial
HAIN
$49.1M
| $127M | 0.37% |
1,978,114
+79,241
| +4% | +$4.69M |
|
41
Chevron
CVX
$388B
| $126M | 0.37% |
1,199,627
+73,246
| +7% | +$7.82M |
|
|
RAD
42
DELISTED
Rite Aid Corporation
RAD
| $126M | 0.37% |
723,938
+718,484
| +13,174% | +$112M |
|
43
Apple
AAPL
$4.78T
| $120M | 0.35% |
3,842,104
-583,972
| -13% | -$17.6M |
|
44
Cencora
COR
$59.4B
| $119M | 0.35% |
1,045,168
+100,687
| +11% | +$10.1M |
|
45
Verizon
VZ
$187B
| $118M | 0.35% |
2,431,729
-183,643
| -7% | -$8.86M |
|
46
Netflix
NFLX
$287B
| $118M | 0.35% |
19,859,770
-2,585,940
| -12% | -$15.7M |
|
47
Myriad Genetics
MYGN
$538M
| $118M | 0.35% |
3,326,239
+449,817
| +16% | +$16.1M |
|
|
QGENF
48
DELISTED
QIAGEN NV
QGENF
| $118M | 0.35% |
4,662,868
+1,360,400
| +41% | +$34.3M |
|
49
Novavax
NVAX
$1.28B
| $117M | 0.34% |
+705,902
| New | +$115M |
|
|
AGN
50
DELISTED
Allergan plc
AGN
| $116M | 0.34% |
389,070
+115,457
| +42% | +$32.9M |
|
Similar funds
DAM
First Trust Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, First Trust Advisors held 2,403 positions worth $34B, up 15% from $29.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
First Trust Advisors deployed $3.11B of net new capital in Q1 2015, opening 160 new positions and adding to 1,020 existing holdings. Its largest new stake was Novavax: 705,902 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was PepsiCo, an estimated $54.5M trimmed.
- First Trust Advisors's largest Q1 2015 buy was Novavax: 705,902 shares worth $117M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q1 2015, an estimated $308M increase.
- First Trust Advisors's biggest Q1 2015 reduction was PepsiCo, cutting an estimated $54.5M.
- First Trust Advisors fully exited CUBIST PHARMACEUTICALS INC in Q1 2015, selling an estimated $96.7M.
- First Trust Advisors's ten largest holdings make up 12% of its $34B portfolio in Q1 2015.
- First Trust Advisors opened 160 new positions and closed 188 in Q1 2015.
- First Trust Advisors's portfolio value rose 15% quarter-over-quarter to $34B.
Based on First Trust Advisors's 13F filing for Q1 2015, filed 4 May 2015.